1. Fidan K, Goknar N, Gulhan B, et al. Extra-Renal manifestations of atypical hemolytic uremic syndrome in children. Pediatr Nephrol. 2018; 33(8):1395-1403. doi:10.1007/s00467-018-3933-3
2. Formeck C, Swiatecka-Urban A. Extra-renal manifestations of atypical hemolytic uremic syndrome. Pediatr Nephrol.2019 ;34(8):1337-1348. doi:10.1007/s00467-018-4039-7
3. Yerigeri K, Kadatane S, Mongan K, et al. Atypical hemolytic-uremic syndrome: genetic basis, clinical manifestations, and a multidisciplinary approach to management. J Multidiscip Healthc.2023;16:2233-2249. doi:10.2147/JMDH.S245620
4. Avila A, Cao M, Espinosa M, Manrique J, Morales E. Recommendations for the individualised management of atypical hemolytic uremic syndrome in adults<strong>. </strong>Front Med (Lausanne). 2023<strong>;</strong>10:1264310. doi:10. 3389/fmed.2023.1264310
5. Polito MS, Machetta F, Fea AM, Eandi CM. Hypertensive choroidopathy in atypical hemolytic-uremic syndrome. Eur J Ophthalmol. 2021;31(2):NP63-NP66. doi:10.1177/1120672119896286
6. Ugarte M, Horgan S, Rassam S, Leong T, Kon CH. Hypertensive choroidopathy: recognizing clinically significant end-organ damage. Acta Ophthalmol.2008;86(2):227-228.doi:10.1111/j.1600-0420.2007. 01030.x
7. Perlman J, Hines E. Systemic diseases with retinal involvement. In: Ophthalmic Pathology: An Atlas and Texbook, Vol 2. WB Saunders; 1985.
8. Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol. 1998;125(4):509-520. doi:10.1016/s0002-9394(99)80192-5